455 related articles for article (PubMed ID: 11390475)
21. Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles.
Pesce S; Carlomagno S; Moretta A; Sivori S; Marcenaro E
J Immunol Res; 2015; 2015():754373. PubMed ID: 25961063
[TBL] [Abstract][Full Text] [Related]
22. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
23. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
24. Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses.
Carlin LM; Eleme K; McCann FE; Davis DM
J Exp Med; 2001 Nov; 194(10):1507-17. PubMed ID: 11714757
[TBL] [Abstract][Full Text] [Related]
25. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
[TBL] [Abstract][Full Text] [Related]
26. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
27. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
Pende D; Biassoni R; Cantoni C; Verdiani S; Falco M; di Donato C; Accame L; Bottino C; Moretta A; Moretta L
J Exp Med; 1996 Aug; 184(2):505-18. PubMed ID: 8760804
[TBL] [Abstract][Full Text] [Related]
28. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L
J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759
[TBL] [Abstract][Full Text] [Related]
29. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.
Valés-Gómez M; Reyburn HT; Erskine RA; Strominger J
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14326-31. PubMed ID: 9826699
[TBL] [Abstract][Full Text] [Related]
30. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells.
Davis DM; Mandelboim O; Luque I; Baba E; Boyson J; Strominger JL
J Exp Med; 1999 Apr; 189(8):1265-74. PubMed ID: 10209043
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous clustering and tyrosine phosphorylation of NK cell inhibitory receptor induced by ligand binding.
Faure M; Barber DF; Takahashi SM; Jin T; Long EO
J Immunol; 2003 Jun; 170(12):6107-14. PubMed ID: 12794140
[TBL] [Abstract][Full Text] [Related]
32. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
33. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
[TBL] [Abstract][Full Text] [Related]
34. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells.
Thananchai H; Makadzange T; Maenaka K; Kuroki K; Peng Y; Conlon C; Rowland-Jones S; Dong T
AIDS; 2009 Jan; 23(2):189-93. PubMed ID: 19098488
[TBL] [Abstract][Full Text] [Related]
36. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
Lian RH; Freeman JD; Mager DL; Takei F
J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
[TBL] [Abstract][Full Text] [Related]
37. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
38. The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells.
Rajagopalan S; Winter CC; Wagtmann N; Long EO
J Immunol; 1995 Nov; 155(9):4143-6. PubMed ID: 7594568
[TBL] [Abstract][Full Text] [Related]
39. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
40. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily.
Cantoni C; Verdiani S; Falco M; Pessino A; Cilli M; Conte R; Pende D; Ponte M; Mikaelsson MS; Moretta L; Biassoni R
Eur J Immunol; 1998 Jun; 28(6):1980-90. PubMed ID: 9645380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
